Article
Artemisinin Reverses Glucocorticoid-Induced Injury in Bone Marrow-Derived Mesenchymal Stem…
Oxidative Medicine and Cellular Longevity · 2021 · Jiankang Fang, author Marta Silva, author Ruohong Lin, author Wenshu Zhou, author Yitan Chen, author Wenhua Zheng, author Juan Gambini, Academic Editor
Key facts
| Title | Artemisinin Reverses Glucocorticoid-Induced Injury in Bone Marrow-Derived Mesenchymal Stem Cells through Regulation of ERK1/2-CREB Signaling Pathway |
|---|---|
| First author | Jiankang Fang, author Marta Silva, author Ruohong Lin, author Wenshu Zhou, author Yitan Chen, author Wenhua Zheng, author Juan Gambini, Academic Editor |
| Journal | Oxidative Medicine and Cellular Longevity |
| Published | Feb 22, 2021 |
| DOI | 10.1155/2021/5574932 |
| Devices mentioned | K973350, K990827 |
| Product codes mentioned | JLX, KQP |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1